Skip to content

Preliminary study on evaluating the effectiveness of outpatient Morita therapy for agoraphobia

Preliminary study on evaluating the effectiveness of outpatient Morita therapy for agoraphobia - Preliminary study on outpatient Morita therapy for agoraphobia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042870
Enrollment
10
Registered
2021-01-06
Start date
2021-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

agoraphobia

Interventions

Structured Morita therapy (sMT) is performed outpatiently every 1-2 weeks for 30 minutes once (60 minutes only for the first time), for a total of 12 times.

Sponsors

Department of Neuropsychiatry, Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) 20 years old and over, under 60 years old 2) Meet the diagnostic criteria for agoraphobiafor of DSM-5 3) Meet Morita neurosis diagnostic criteria

Exclusion criteria

Exclusion criteria: 1) Substance use disorder such as alcohol within 6 months 2) Comorbidity or history of manic episodes or psychotic disorders 3) Psychiatric disorders other than agoraphobia that should be prioritized for treatment 4) Antisocial personality disorder or menatl retardation 5) problems of suicide or self-harm 6) Cerebral organic lesions or cognitive dysfunction within 1 year 7) Physical illness, abuse, or violence interfere with continuation of the treatment

Design outcomes

Primary

MeasureTime frame
PAS(Panic and Agoraphobia Scale)

Secondary

MeasureTime frame
anxiety: GAD-7 depression: PHQ-9 resilience: Resilience scale quality of life: SF-36

Countries

Japan

Contacts

Public ContactHidehito Niimura

Keio University School of Medicine Department of Neuropsychiatry

niimura-hide@keio.jp03-5363-0187

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026